BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 25, 2002
View Archived Issues
Myriad Genetics Raises $57.3M Through Stock Sale From Shelf
About two weeks after filing a shelf registration statement to sell up to $250 million in securities, Myriad Genetics Inc. is raising $57.3 million through a pursuant offering of 3 million shares of stock. (BioWorld Today)
Read More
Altea Series B Raises $17M For Trials Of Lead Products
Read More
Vaccine Against Cervical Cancer Racked Up 100 Percent Efficacy In Placebo-Controlled Human Trial
Read More
From 'Position Of Strength,' QLT Reduces Staff 18 Percent
Read More
Other News To Note
Read More
Appointments And Announcements
Read More
Correction
Read More